NCT06093490 (DASHER) is a clinical trial of Eysz Hyperventilation Recorder in Absence Epilepsy, Childhood, sponsored by Eysz, Inc..

Who is sponsoring NCT06093490?

NCT06093490 is sponsored by Eysz, Inc..

What drugs are being tested in NCT06093490?

Interventions in NCT06093490: Eysz Hyperventilation Recorder.

What condition does NCT06093490 study?

NCT06093490 studies Absence Epilepsy, Childhood, Absence Seizures, Absence Epilepsy, Epilepsy in Children, Staring, Seizures.

Is NCT06093490 still recruiting?

NCT06093490 is currently completed. Last updated 15 October 2025.

Last reviewed 2025-10-15 · How we verify

NCT06093490: DASHER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Detecting Absence Seizures Using Hyperventilation and Eye Movement Recordings

Completed Last updated 15 October 2025

What this trial tests

trial testing Eysz Hyperventilation Recorder in Absence Epilepsy, Childhood in 65 participants. Completed in 30 July 2025.

Timeline

1 December 2023

Primary endpoint
30 June 2025

30 July 2025

Quick facts

Lead sponsor	Eysz, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	65
Start date	1 December 2023
Primary completion	30 June 2025
Estimated completion	30 July 2025
Sites	1 location across United States

Drugs / interventions tested

Eysz Hyperventilation Recorder

Conditions studied

Absence Epilepsy, Childhood — all drugs for Absence Epilepsy, Childhood →
Absence Seizures — all drugs for Absence Seizures →
Absence Epilepsy — all drugs for Absence Epilepsy →
Epilepsy in Children — all drugs for Epilepsy in Children →

Sponsor

Eysz, Inc.

Who can join

Adults 4 to 12, any sex, with Absence Epilepsy, Childhood or Absence Seizures. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being done to find out if a smartphone app can identify absence seizures. Children who have a history of absence seizures, as well as children without any seizure history, will be testing out the app. If participating the child will be guided through hyperventilation, an activity that asks the child to take quick, deep breaths. The app will record video of the child's face and sounds they make during hyperventilation. Hyperventilation is a safe and established technique frequently used during EEG (electroencephalogram) to encourage seizure occurrence. The App will be used during a regularly scheduled EEG.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Eysz, Inc. trials

Trials by the same sponsor.

NCT06310772 — Assessing Comorbidities in Epilepsy Using Eye Movement Recordings · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06093490 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eysz, Inc.
Last refreshed: 15 October 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06093490.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing